| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Perspective Therapeutics, Inc. (CATX) has 8 insiders with recent SEC Form 4 filings, including 14 buys and 1 sell. CATX is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 735.0K | $2.21M | - | |
| CFO | 600.0K | $1.80M | - | |
| Other | 150.0K | $450.0K | - | |
| Other | 90.0K | $270.0K | - | |
| Dir | 75.0K | $225.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2016 | Lavoy Thomas C | CEO | Buy | 36,706 | $0.89 | $32,535.30 | +17.3% | |
| Mar 11, 2016 | Vitale Philip J | Director | Buy | 10,000 | $0.93 | $9,319.00 | +100.0% | |
| Mar 8, 2016 | McCormick Michael W | Director | Buy | 22,000 | $0.87 | $19,074.00 | New | |
| Nov 12, 2015 | Babcock Dwight William | CEO | Buy | 25,000 | $1.27 | $31,737.00 | +2.8% | |
| Jun 9, 2015 | Babcock Dwight William | CEO | Buy | 10,000 | $1.53 | $15,298.49 | +1.1% | |
| Apr 2, 2015 | Cavanagh William | Vice President | Sale+OE | 13,340 | $1.53 | $20,410.20 | -100% | |
| Mar 6, 2015 | Lavoy Thomas C | Director | Buy | 10,000 | $1.66 | $16,600.00 | +12.0% | |
| Mar 5, 2015 | Vitale Philip J | Director | Buy | 10,000 | $1.80 | $17,999.00 | New | |
| Mar 3, 2015 | Babcock Dwight William | CEO | Buy | 10,029 | $1.51 | $15,143.79 | +1.8% |